XGN
EXAGEN INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$7.43
−3.76%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 14.73x
- Price / sales
- 2.53x
- Price / cash flow
- -27.70x
Enterprise value
- Enterprise value
- $181.0M
- EV / sales
- 2.54x
- EV / EBITDA
- -15.99x
- EV / EBIT
- -13.70x
- Market cap
- $180.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026